Is melatonin safe? What NIH and label-testing studies report

What does this page read, and what does it leave out?

The main source is the NIH National Center for Complementary and Integrative Health page on melatonin, read in full.^[1] It also reads FDA's page on how dietary supplements are regulated, the PubMed abstract of a 2017 label-testing study, and the CDC's March 2024 MMWR report.^[2][3][4]

The 2023 JAMA gummies paper's text was not available, so its figures are quoted as NCCIH describes them.^[5] No dose appears here, and for trial depth and what NIH says melatonin does, see the sleep and melatonin trial-record guide.

What does NIH say about safety?

NCCIH says short-term use of melatonin supplements appears to be safe for most people, and that information on long-term safety is lacking.^[1] For doses higher than the body normally produces, it says there is not enough information on side effects for a clear picture of overall safety.

• A 2015 review found only mild effects in short-term studies of adults, surgical patients and critically ill patients: headache, dizziness, nausea and sleepiness.
• People with epilepsy and people taking blood thinners need to be under medical supervision, and there may be a risk of allergic reaction.
• Research on safety in pregnant or breastfeeding women is lacking, and the American Academy of Sleep Medicine's 2015 guidelines recommend against melatonin in people with dementia.
• Melatonin may stay active longer in older people and cause daytime drowsiness.
• Practice guidelines from the American Academy of Sleep Medicine (2017) and the American College of Physicians (2016) say there is not enough strong evidence on effectiveness or safety of melatonin for chronic insomnia to recommend its use.

Does the label match what is inside?

In the United States melatonin is sold as a dietary supplement, and NCCIH says that means it is regulated less strictly than a prescription or over-the-counter drug.^[1] FDA says firms must evaluate the safety and labeling of their products before marketing, and that it can act against an adulterated or misbranded product once it reaches the market.^[2]

• A 2017 study analyzed 31 supplements and found melatonin from 83% below to 478% above the labeled content, with lot-to-lot variation in one product as high as 465%.^[3]
• Melatonin missed the label by more than a 10% margin in more than 71% of those supplements, and 8 of the 31 contained serotonin, a controlled substance used in neurological treatment, at 1 to 75 micrograms.
• NCCIH describes a 2023 JAMA study in which 22 of 25 gummy products were inaccurately labeled, one had no detectable melatonin, and the rest held 74 to 347% of the labeled amount.^[5]
• The authors of the 2017 study say manufacturers need more controls so that products meet their label claim and are free of contaminants such as serotonin.

How common is use, and what about storage?

The CDC report says the share of US adults using melatonin quintupled from 0.4% in 1999 to 2000 to 2.1% in 2017 to 2018.^[4] It also estimates about 10,930 emergency department visits for unsupervised melatonin ingestion by children aged 5 and under in 2019 to 2022.

• Almost half of those visits (47.3%) involved gummies, and 93.5% did not end in hospitalization.
• The CDC says the finding underlines keeping all medications and supplements, including gummies, out of children's reach and sight.

1. Do you take a blood thinner or have epilepsy? NIH says both need medical supervision.
2. Pregnant, nursing, or planning either? NIH notes research on safety is lacking.
3. Older, or caring for someone with dementia? AASM guidelines advise against use in dementia.
4. Taking it every night for months? NIH says long-term safety information is lacking.
5. How do you know what is in the product? Studies found large gaps from the label.
6. Any allergic reaction before? NIH lists allergic reaction as a possible risk.

How much research looks at the side effects?

PubMed holds 1,216 papers on melatonin and sleep that mention adverse or side effects, safety, toxicity or overdose, which is 18 percent of the 6,594 papers in the trial-record guide.^[6] Of the 1,216, 174 are typed as randomized controlled trials^[7] and 120 as reviews or meta-analyses.

• A word match includes papers that mention safety only to say it was not measured, and it says nothing about how often anything happens.
• It shows that safety has been studied well beyond NIH's summary, and that this page has not read that research.

How should you use this page?

• If you are asking whether it is safeShort term, probably; long term, unknownNIH calls short-term use safe for most people and says long-term information is lacking. Medicines, pregnancy and age change the picture, so ask a clinician.
• If you are choosing a productTreat the label as approximateTesting found large gaps between label and contents, including serotonin in some products. This page tests nothing and names no brand.
• If you hope it fixes chronic insomniaThe guidelines are not behind itThe two guidelines NIH cites say the evidence on effectiveness and safety is not strong enough to recommend melatonin for chronic insomnia.

How this page was built

FAQ

Bottom line

NIH says short-term melatonin appears safe for most people and that long-term safety information is lacking, and testing studies show the amount in a bottle can be far from the label. Hold any claim of "totally harmless" or "exactly the dose on the label" up against that wording, then ask a clinician about your own medicines and situation.

Whitepill editorial desk. (2026, November 2). Is melatonin safe? What NIH and label-testing studies report. Whitepill. https://whitepill.dev/articles/is-melatonin-safe-what-nih-and-label-studies-report

@online{whitepill_is_melatonin_safe_what, author = {{Whitepill editorial desk}}, title = {Is melatonin safe? What NIH and label-testing studies report}, year = {2026}, month = nov, url = {https://whitepill.dev/articles/is-melatonin-safe-what-nih-and-label-studies-report}, note = {Last modified 2026-11-02}
}